-

05:28:51 AM

ANIP Stock News

ANIP - ANI Pharmaceuticals Inc

10/29/21 4:30 PM

Nasdaq : ANIP

earningslow float

ANI Pharmaceuticals to Discuss Third Quarter 2021 Financial Results on November 1, 2021

ANI Pharmaceuticals, Inc. today announced that the Company will release its third quarter 2021 financial results on Monday, November 1, 2021. Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a conference call to discuss the results as follows:.

RHEA-AI

neutral

09/20/21 4:30 PM

Nasdaq : ANIP

conferenceslow float

ANI Pharmaceuticals to Present at Cantor Virtual Global Healthcare Conference 2021

ANI Pharmaceuticals, Inc. today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Cantor Virtual Global Healthcare Conference 2021 as follows:. About ANI ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and...

RHEA-AI

neutral

09/17/21 6:50 AM

Nasdaq : ANIP

low float

ANI Pharmaceuticals Announces Launch of Nebivolol Tablets

ANI Pharmaceuticals, Inc. today announced the launch of Nebivolol Tablets, 2.5 mg, 5 mg, 10 mg, and 20 mg. On day one, we simultaneously launched across two manufacturing sites, including our site in Baudette, Minnesota, thus showcasing our ability to secure the supply chain for patients and customers,” stated Nikhil Lalwani, President and CEO of ANI Pharmaceuticals,...

RHEA-AI

neutral

08/31/21 6:50 AM

Nasdaq : ANIP

low float

ANI Pharmaceuticals Announces FDA Acceptance of Purified Cortrophin® Gel Supplemental New Drug Application for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis, and Nephrotic Syndrome

ANI Pharmaceuticals, Inc. today announced that the Company’ s supplemental New Drug Application for Purified Cortrophin ® Gel has been accepted by the U.S. Food and Drug Administration for review. We look forward to further productive engagement with the FDA, and in parallel, we are focused on preparations for the launch of Cortrophin Gel,” stated Nikhil...

RHEA-AI

neutral

08/06/21 7:24 AM

Nasdaq : ANIP

low float

ANI Pharmaceuticals Reports Second Quarter 2021 Results

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced business highlights and financial results for the three and six months ended June 30, 2021.Second Quarter and Recent Business Highlights :The Company refiled its supplemental new drug application (“sNDA”) for

RHEA-AI

neutral

07/22/21 4:30 PM

Nasdaq : ANIP

earningslow float

ANI Pharmaceuticals to Discuss Second Quarter 2021 Financial Results on August 6, 2021

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2021 financial results on Friday, August 6, 2021.Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and

RHEA-AI

neutral

07/06/21 6:50 AM

Nasdaq : ANIP

low float

ANI Pharmaceuticals Announces Refiling of Cortrophin sNDA with FDA

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that the Company has re-filed its supplemental new drug application (“sNDA”) for Cortrophin ® Gel with the U.S. Food and Drug Administration (“FDA”).“We are delighted to have re-filed our sNDA for Cortrophin Gel in

RHEA-AI

neutral

06/15/21 4:05 PM

Nasdaq : ANIP

conferenceslow float

ANI Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference 2021

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Raymond James Human Health Innovation Conference 2021 as follows:Date:Tuesday, June 22,

RHEA-AI

neutral

06/01/21 4:05 PM

Nasdaq : ANIP

low float

ANI Pharmaceuticals Announces Details of 2021 Virtual Annual Meeting of Stockholders

ANI Pharmaceuticals, Inc. (“ANI“ or the “Company“) (Nasdaq: ANIP) today announced log-in details for its 2021 Virtual Annual Meeting of Stockholders to be held on June 2, 2021, beginning at 10 a.m. Eastern Time.Stockholders can attend the virtual annual meeting via the internet at

RHEA-AI

neutral

05/27/21 4:30 PM

Nasdaq : ANIP

conferenceslow float

ANI Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference 2021

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Conference 2021 as follows:Date:Friday, June 4, 2021Time:10:00 a.m.

RHEA-AI

neutral

Prev 1 2 3 4 Next

ANIP Data:

IndustryBiological Product (except Diagnostic) Manufacturing
Websitewww.anipharmaceuticals.com
CeoPatrick Walsh
Security nameANI Pharmaceuticals Inc
Issue typecs
SectorManufacturing
Sic code2834
Tags
- Health Technology
- Pharmaceuticals: Other
- Manufacturing
- Biological Product (except Diagnostic) Manufacturing
Address210 W Main St
StateMinnesota
CityBaudette
Zip56623-2467
CountryUS
Phone12186343500

ANIP Description:

ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The Company's targeted areas of product development currently include narcotics, oncolytics (anti-cancers), hormones and steroids, and complex formulations involving extended release and combination products.